ArticleBone reports2016

Effect of four monthly doses of a human monoclonal anti-FGF23 antibody (KRN23) on quality of life in X-linked hypophosphatemia.

Mary D Ruppe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.